1. Home
  2. DMTK

DMTK

DermTech Inc.

Logo DermTech Inc.

Health Care

Medical Specialities

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

DermTech Inc is an emerging growth molecular diagnostic company. The company is engaged in marketing and developing novel non-invasive genomic tests to aid in the diagnosis of various skin conditions, including skin cancer, inflammatory diseases, and aging-related conditions. While the company generates revenue through laboratory services.

Founded: N/A Country:
United States
United States
Employees: N/A City: SAN DIEGO
Market Cap: 22.5M IPO Year: N/A
Target Price: $1.75 AVG Volume (30 days): 311.9K
Analyst Decision: Buy Number of Analysts: 2
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -3.09 EPS Growth: N/A
52 Week Low/High: $0.61 - $4.67 Next Earning Date: 05-02-2024
Revenue: $15,296,000 Revenue Growth: 5.36%
Revenue Growth (this year): 19.74% Revenue Growth (next year): 19.86%

Share on Social Networks: